These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15313907)

  • 21. Immunohistochemical analysis of MUC5B apomucin expression in breast cancer and non-malignant breast tissues.
    Sóñora C; Mazal D; Berois N; Buisine MP; Ubillos L; Varangot M; Barrios E; Carzoglio J; Aubert JP; Osinaga E
    J Histochem Cytochem; 2006 Mar; 54(3):289-99. PubMed ID: 16148312
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.
    Parr C; Gan CH; Watkins G; Jiang WG
    Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peripheral-type benzodiazepine receptor overexpression and knockdown in human breast cancer cells indicate its prominent role in tumor cell proliferation.
    Li W; Hardwick MJ; Rosenthal D; Culty M; Papadopoulos V
    Biochem Pharmacol; 2007 Feb; 73(4):491-503. PubMed ID: 17126818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: comparison to antigen quantification by ELISA.
    Biermann JC; Holzscheiter L; Kotzsch M; Luther T; Kiechle-Bahat M; Sweep FC; Span PN; Schmitt M; Magdolen V
    Int J Mol Med; 2008 Feb; 21(2):251-9. PubMed ID: 18204793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel genes that co-cluster with estrogen receptor alpha in breast tumor biopsy specimens, using a large-scale real-time reverse transcription-PCR approach.
    Tozlu S; Girault I; Vacher S; Vendrell J; Andrieu C; Spyratos F; Cohen P; Lidereau R; Bieche I
    Endocr Relat Cancer; 2006 Dec; 13(4):1109-20. PubMed ID: 17158757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic background of different cancer cell lines influences the gene set involved in chromosome 8 mediated breast tumor suppression.
    Seitz S; Korsching E; Weimer J; Jacobsen A; Arnold N; Meindl A; Arnold W; Gustavus D; Klebig C; Petersen I; Scherneck S
    Genes Chromosomes Cancer; 2006 Jun; 45(6):612-27. PubMed ID: 16552773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular characterization of breast cancer cell lines by a low-density microarray.
    de Longueville F; Lacroix M; Barbuto AM; Bertholet V; Gallo D; Larsimont D; Marcq L; Zammatteo N; Boffe S; Leclercq G; Remacle J
    Int J Oncol; 2005 Oct; 27(4):881-92. PubMed ID: 16142302
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The expression and functional characterization of sigma (sigma) 1 receptors in breast cancer cell lines.
    Aydar E; Onganer P; Perrett R; Djamgoz MB; Palmer CP
    Cancer Lett; 2006 Oct; 242(2):245-57. PubMed ID: 16388898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
    Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
    Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of sigma 1 receptor in human breast cancer.
    Wang B; Rouzier R; Albarracin CT; Sahin A; Wagner P; Yang Y; Smith TL; Meric-Bernstam F; Marcelo Aldaz C; Hortobagyi GN; Pusztai L
    Breast Cancer Res Treat; 2004 Oct; 87(3):205-14. PubMed ID: 15528963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolactin and human tumourogenesis.
    Fernandez I; Touraine P; Goffin V
    J Neuroendocrinol; 2010 Jul; 22(7):771-7. PubMed ID: 20456598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.
    Ginsburg E; Alexander S; Lieber S; Tarplin S; Jenkins L; Pang L; Heger CD; Goldsmith P; Vonderhaar BK
    BMC Cancer; 2010 Dec; 10():678. PubMed ID: 21144038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization and modulation of a prolactin receptor mRNA isoform in normal and tumoral human breast tissues.
    Laud K; Gourdou I; Belair L; Peyrat JP; Djiane J
    Int J Cancer; 2000 Mar; 85(6):771-6. PubMed ID: 10709093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maintenance of prolactin receptors in human breast cancer.
    Ben-David M; Dror Y; Biran S
    Isr J Med Sci; 1981; 17(9-10):965-9. PubMed ID: 6273360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothesis: prolactin is tumorigenic to human breast: dispelling the myth that prolactin-induced mammary tumors are rodent-specific.
    Harvey PW
    J Appl Toxicol; 2012 Jan; 32(1):1-9. PubMed ID: 22095846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop.
    Clevenger CV; Chang WP; Ngo W; Pasha TL; Montone KT; Tomaszewski JE
    Am J Pathol; 1995 Mar; 146(3):695-705. PubMed ID: 7534043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variation in the coding and 3' untranslated regions of the porcine prolactin receptor short form modifies protein expression and function.
    Trott JF; Freking BA; Hovey RC
    Anim Genet; 2014 Feb; 45(1):74-86. PubMed ID: 24350599
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prolactin receptors in human breast tumors.
    Turcot-Lemay L; Kelly PA
    J Natl Cancer Inst; 1982 Mar; 68(3):381-3. PubMed ID: 6278192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.